Showing results (111-120 of 413) with videos related to
Sort By:
Pageof 42
Cancer|May 31, 2013
The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcomeAndrew J Vickers, Daniel D Sjoberg, Donna P Ankerst, et al.Current Urology Reports|May 5, 2005
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?Edith D Canby-Hagino, Gregory P Swanson, E David Crawford, et al.JAMA|January 18, 2006
Erectile dysfunction and subsequent cardiovascular diseaseIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.World Journal of Urology|November 23, 2017
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomyMark Thalgott, Martina Kron, Johannes M Brath, et al.Neoplasia (New York, N.Y.)|November 22, 2007
Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutineRita Ghosh, Gretchen E Garcia, Katherine Crosby, et al.Urologic Oncology|February 7, 2012
Prostate cancer risk prediction in a urology clinic in MexicoYuanyuan Liang, Jamie C Messer, Christopher Louden, et al.Cancer Epidemiology|October 23, 2019
Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMICatherine M Tangen, Jeannette Schenk, Cathee Till, et al.World Journal of Urology|May 21, 2003
The selenium and vitamin E cancer prevention trialEric A Klein, Scott M Lippman, Ian M Thompson, et al.Plos One|October 10, 2018
The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trialJavier Hernandez, Jonathan Gelfond, Martin Goros, et al.European Urology|March 31, 2012
Finasteride reduces the risk of incident clinical benign prostatic hyperplasiaJ Kellogg Parsons, Jeannette M Schenk, Kathryn B Arnold, et al.Pageof 42